Latest Press Releases Number of shares and voting rights of Innate Pharma as of December 31, 2025 January 7, 2026 Number of shares and voting rights of Innate Pharma as of December 18, 2025 December 22, 2025 Innate Pharma releases its 2026 financial calendar December 11, 2025 Selected media Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
